Gennex Laboratories Limited (GENNEX.BO)
INR 13.87
(0.14%)
INR 13.87
(0.14%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 535.21 Million INR | 16.86% |
| 2022 | 458.01 Million INR | 89.17% |
| 2021 | 242.11 Million INR | 26.15% |
| 2020 | 191.92 Million INR | -9.78% |
| 2019 | 212.72 Million INR | 18.74% |
| 2018 | 179.15 Million INR | -4.19% |
| 2017 | 186.98 Million INR | 2.32% |
| 2016 | 182.74 Million INR | 34.87% |
| 2015 | 135.49 Million INR | -0.94% |
| 2014 | 136.78 Million INR | -3.69% |
| 2013 | 142.02 Million INR | 27.18% |
| 2012 | 111.67 Million INR | 16.43% |
| 2011 | 95.91 Million INR | 149.15% |
| 2010 | 38.49 Million INR | -17.36% |
| 2009 | 46.58 Million INR | -57.74% |
| 2008 | 110.23 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 535.21 Million INR | 16.86% |
| 2023 Q4 | 535.21 Million INR | 0.0% |
| 2023 Q2 | 395.4 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 458.01 Million INR | 89.17% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 200.3 Million INR | 0.0% |
| 2022 Q4 | 458.01 Million INR | 0.0% |
| 2021 Q2 | 229.19 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 242.11 Million INR | 26.15% |
| 2021 Q4 | 242.11 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 191.92 Million INR | -9.78% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 196.18 Million INR | 0.0% |
| 2020 Q2 | 207.41 Million INR | 0.0% |
| 2019 Q4 | 212.72 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 195.8 Million INR | 0.0% |
| 2019 FY | 212.72 Million INR | 18.74% |
| 2018 Q2 | 166.32 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 179.15 Million INR | -4.19% |
| 2018 Q4 | 179.15 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q4 | 186.98 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 170.13 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 186.98 Million INR | 2.32% |
| 2016 FY | 182.74 Million INR | 34.87% |
| 2016 Q2 | 155.52 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 182.77 Million INR | 0.0% |
| 2015 FY | 135.49 Million INR | -0.94% |
| 2015 Q4 | 135.49 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 144.65 Million INR | 0.0% |
| 2014 Q2 | 141.12 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 136.78 Million INR | -3.69% |
| 2014 Q4 | 136.78 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 138.49 Million INR | 0.0% |
| 2013 Q4 | 142.02 Million INR | 0.0% |
| 2013 FY | 142.02 Million INR | 27.18% |
| 2012 Q4 | 111.67 Million INR | 0.0% |
| 2012 FY | 111.67 Million INR | 16.43% |
| 2011 FY | 95.91 Million INR | 149.15% |
| 2011 Q4 | 91.49 Million INR | 0.0% |
| 2010 Q4 | 38.49 Million INR | 0.0% |
| 2010 FY | 38.49 Million INR | -17.36% |
| 2009 FY | 46.58 Million INR | -57.74% |
| 2008 Q4 | 110.23 Million INR | 0.0% |
| 2008 FY | 110.23 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Sunil Healthcare Limited | 902.83 Million INR | 40.718% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 67.789% |
| BDH Industries Limited | 312.53 Million INR | -71.249% |
| Deccan Health Care Limited | 111.33 Million INR | -380.718% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -354.629% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -171.168% |
| Hindustan Bio Sciences Limited | 25.7 Million INR | -1982.451% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -5932.597% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -165.493% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 46.283% |
| MedPlus Health Services Limited | 14.27 Billion INR | 96.251% |
| Patidar Buildcon Limited | 25.57 Million INR | -1992.961% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -236.18% |
| Bacil Pharma Limited | 1.12 Million INR | -47305.846% |
| Beryl Drugs Limited | 85.63 Million INR | -524.985% |
| Cian Healthcare Limited | 1.03 Billion INR | 48.256% |
| Concord Drugs Limited | 249.88 Million INR | -114.182% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -245.153% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -231.044% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 64.333% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -178900.669% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -1175.164% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 68.778% |
| Syschem (India) Limited | 1.07 Billion INR | 50.014% |
| Medi-Caps Limited | 63.01 Million INR | -749.327% |
| Parmax Pharma Limited | 117.56 Million INR | -355.237% |
| Smruthi Organics Limited | 485.72 Million INR | -10.189% |
| Phaarmasia Limited | 211.49 Million INR | -153.061% |
| Transchem Limited | 6.72 Million INR | -7864.464% |
| Trinity League India Limited | 876 Thousand INR | -60997.26% |
| Tyche Industries Limited | 101.64 Million INR | -426.571% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -205.544% |
| Zenith Healthcare Limited | 24.03 Million INR | -2126.803% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -25050.94% |
| Colinz Laboratories Limited | 24.1 Million INR | -2120.336% |
| Denis Chem Lab Limited | 289.82 Million INR | -84.669% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 68.815% |
| Makers Laboratories Limited | 569.18 Million INR | 5.968% |
| Panchsheel Organics Limited | 340.2 Million INR | -57.322% |
| Parnax Lab Limited | 1.17 Billion INR | 54.283% |
| PRAVEG LIMITED | 767.53 Million INR | 30.269% |
| Mercury Laboratories Limited | 171.18 Million INR | -212.644% |
| Trident Lifeline Limited | 331.26 Million INR | -61.568% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -83.621% |
| Vivanza Biosciences Limited | 148.63 Million INR | -260.094% |
| Zenlabs Ethica Limited | 301.35 Million INR | -77.602% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -2449.843% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -897.655% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 46.71% |
| Roopa Industries Limited | 493.08 Million INR | -8.543% |
| PANJON LTD. | 25.38 Million INR | -2008.545% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -156.769% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -3473.082% |
| Anuh Pharma Limited | 1.54 Billion INR | 65.35% |
| Crestchem Limited | 23.94 Million INR | -2134.986% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -3892.63% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -352.714% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 71.245% |
| Trimurthi Limited | 101.36 Thousand INR | -527930.781% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -164.991% |
| Norris Medicines Limited | 278.17 Million INR | -92.402% |
| Veerhealth Care Limited | 62.78 Million INR | -752.52% |
| Lactose (India) Limited | 536.39 Million INR | 0.221% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 35.76% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 52.674% |
| Godavari Drugs Limited | 957.86 Million INR | 44.124% |
| Zenotech Laboratories Limited | 156.64 Million INR | -241.665% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | -9.592% |
| Bharat Parenterals Limited | 2.65 Billion INR | 79.853% |
| Coral Laboratories Limited | 281.83 Million INR | -89.9% |
| Evoq Remedies Limited | 116.23 Million INR | -360.469% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 49.396% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 73.803% |
| Natural Capsules Limited | 1.47 Billion INR | 63.769% |
| Auro Laboratories Limited | 433.09 Million INR | -23.578% |